Thus, given the role of AMPK in enabling the proliferation of anti-tumor immunity via T cell differentiation, it is hypothesized that metformin may synergize with immunotherapy, particularly the PD-1 blockade. The gene discussed is PDCD1; the disease is neoplasm.